CVS Health Corporation
CVS
$65.75
$0.911.40%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -44.70% | -41.89% | 142.50% | 78.87% | 93.55% |
| Total Depreciation and Amortization | 5.29% | 7.23% | 8.38% | 7.83% | 3.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -130.39% | -35.44% | -84.53% | -68.63% | -14.93% |
| Change in Net Operating Assets | 626.67% | -1,692.24% | -132.74% | -112.26% | -99.78% |
| Cash from Operations | -32.17% | -67.32% | -60.66% | -45.69% | -17.01% |
| Capital Expenditure | 8.25% | -4.13% | 1.55% | -3.46% | -11.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 99.43% | 98.76% | 98.72% | -32.06% | -11,851.08% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -280.18% | -355.50% | -134.05% | -402.08% | -33.69% |
| Cash from Investing | 63.55% | 57.97% | 71.05% | -25.08% | -313.89% |
| Total Debt Issued | -38.92% | -63.78% | -75.39% | 112.84% | -- |
| Total Debt Repaid | 41.55% | 72.41% | 82.93% | -71.57% | -93.92% |
| Issuance of Common Stock | 30.32% | 33.22% | 19.20% | 9.71% | -49.73% |
| Repurchase of Common Stock | -46.28% | 13.76% | 13.85% | 17.12% | 43.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -7.69% | -7.88% | -7.85% | -7.73% | -7.74% |
| Other Financing Activities | 112.94% | 92.35% | -80.33% | -82.76% | -154.43% |
| Cash from Financing | -142.30% | -272.89% | -485.11% | 75.29% | 125.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.51% | -48.88% | -178.55% | -244.98% | -878.50% |
